People · Operator
Named in public records as an officer, director or promoter · active 2009–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Onconova Therapeutics, Inc. | — | Biotechnology | Series C | $124.6M | $137.2M | 2009 |
| BlinkBio, Inc. | — | Biotechnology | Series B | $43.6M | $20.8M | 2009 |
Viren Mehta at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Viren Mehta on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Pankaj Patel | 1 | 9 |
| Mark Simon | 1 | 6 |
| Geoff Smith | 1 | 6 |
| Werner Cautreels | 1 | 5 |
| Colin Goddard | 1 | 5 |
| Derek Small | 1 | 4 |
| Douglas Reed | 1 | 4 |
| Alan Lewis | 1 | 4 |
| Nikolay Savchuk | 1 | 3 |
| James Schulz | 1 | 3 |
| Jack E. Stover | 1 | 2 |
| Jutta Wanner | 1 | 2 |
| Thomas M. McKearn | 1 | 2 |
| Michael Gargano | 1 | 2 |
| Kapil Dhingra | 1 | 2 |
| Anne M. VanLent | 1 | 2 |
| Michael M. Hoffman | 1 | 2 |
| Henry S. Bienen, Ph.D. | 1 | 1 |
| K Ravindra | 1 | 1 |
| Henry S. Bienen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.